Brief: Caribou Biosciences Presents Case Report On Long-Term Follow Up Of First Patient Dosed In Phase 1 Antler Trial
18/10/2022 14:35
Oct 18 (Reuters) - Caribou Biosciences Inc CRBU.O :
* CARIBOU BIOSCIENCES PRESENTS CASE REPORT ON LONG-TERM
FOLLOW UP
OF FIRST PATIENT DOSED IN PHASE 1 ANTLER TRIAL AT THE LYMPHOMA,
LEUKEMIA, & MYELOMA CONGRESS 2022
Source text for Eikon: ID:nGNX1JCY0w
Further company coverage: CRBU.O
((Reuters.Briefs@thomsonreuters.com;))